PortfoliosLab logoPortfoliosLab logo
ACRV vs. SSO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ACRV vs. SSO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Acrivon Therapeutics Inc. Common Stock (ACRV) and ProShares Ultra S&P500 (SSO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ACRV achieves a -37.34% return, which is significantly lower than SSO's 19.37% return.


ACRV

1D
-3.82%
1M
-30.41%
YTD
-37.34%
6M
-33.77%
1Y
30.17%
3Y*
-50.39%
5Y*
10Y*

SSO

1D
-1.40%
1M
9.75%
YTD
19.37%
6M
18.81%
1Y
52.69%
3Y*
37.56%
5Y*
19.62%
10Y*
24.21%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ACRV vs. SSO - Yearly Performance Comparison


2026 (YTD)2025202420232022
ACRV
Acrivon Therapeutics Inc. Common Stock
-37.34%-59.97%22.36%-57.29%-30.77%
SSO
ProShares Ultra S&P500
19.37%26.19%43.48%46.65%-8.25%

Correlation

The correlation between ACRV and SSO is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.30

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Nov 16, 2022

0.25

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ACRV vs. SSO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ACRV
ACRV Risk / Return Rank: 5555
Overall Rank
ACRV Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
ACRV Sortino Ratio Rank: 5858
Sortino Ratio Rank
ACRV Omega Ratio Rank: 5858
Omega Ratio Rank
ACRV Calmar Ratio Rank: 5353
Calmar Ratio Rank
ACRV Martin Ratio Rank: 5252
Martin Ratio Rank

SSO
SSO Risk / Return Rank: 6262
Overall Rank
SSO Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
SSO Sortino Ratio Rank: 5959
Sortino Ratio Rank
SSO Omega Ratio Rank: 6060
Omega Ratio Rank
SSO Calmar Ratio Rank: 5858
Calmar Ratio Rank
SSO Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ACRV vs. SSO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Acrivon Therapeutics Inc. Common Stock (ACRV) and ProShares Ultra S&P500 (SSO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ACRVSSODifference

Sharpe ratio

Return per unit of total volatility

0.33

2.25

-1.92

Sortino ratio

Return per unit of downside risk

1.18

2.86

-1.68

Omega ratio

Gain probability vs. loss probability

1.15

1.38

-0.23

Calmar ratio

Return relative to maximum drawdown

0.53

2.91

-2.38

Martin ratio

Return relative to average drawdown

1.07

12.80

-11.73

ACRV vs. SSO - Sharpe Ratio Comparison

The current ACRV Sharpe Ratio is 0.33, which is lower than the SSO Sharpe Ratio of 2.25. The chart below compares the historical Sharpe Ratios of ACRV and SSO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ACRVSSODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.33

2.25

-1.92

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.59

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.68

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.48

0.42

-0.89

Drawdowns

ACRV vs. SSO - Drawdown Comparison

The maximum ACRV drawdown since its inception was -95.47%, which is greater than SSO's maximum drawdown of -84.67%. Use the drawdown chart below to compare losses from any high point for ACRV and SSO.


Loading charts...

Drawdown Indicators


ACRVSSODifference

Max Drawdown

Largest peak-to-trough decline

-95.47%

-84.67%

-10.80%

Max Drawdown (1Y)

Largest decline over 1 year

-57.14%

-18.17%

-38.97%

Max Drawdown (3Y)

Largest decline over 3 years

-92.31%

-35.21%

-57.10%

Max Drawdown (5Y)

Largest decline over 5 years

-46.73%

Max Drawdown (10Y)

Largest decline over 10 years

-59.34%

Current Drawdown

Current decline from peak

-93.49%

-1.40%

-92.09%

Average Drawdown

Average peak-to-trough decline

-70.41%

-19.57%

-50.84%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.20%

4.13%

+24.07%

Volatility

ACRV vs. SSO - Volatility Comparison

Acrivon Therapeutics Inc. Common Stock (ACRV) has a higher volatility of 16.57% compared to ProShares Ultra S&P500 (SSO) at 5.66%. This indicates that ACRV's price experiences larger fluctuations and is considered to be riskier than SSO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ACRVSSODifference

Volatility (1M)

Calculated over the trailing 1-month period

16.57%

5.66%

+10.91%

Volatility (6M)

Calculated over the trailing 6-month period

73.77%

17.78%

+55.99%

Volatility (1Y)

Calculated over the trailing 1-year period

92.44%

23.60%

+68.84%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

103.89%

33.65%

+70.24%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

103.89%

35.89%

+68.00%

Dividends

ACRV vs. SSO - Dividend Comparison

ACRV has not paid dividends to shareholders, while SSO's dividend yield for the trailing twelve months is around 0.62%.


PositionTTM20252024202320222021202020192018201720162015
ACRV
Acrivon Therapeutics Inc. Common Stock
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SSO
ProShares Ultra S&P500
0.62%0.68%0.85%0.18%0.50%0.18%0.20%0.50%0.75%0.39%0.51%0.63%

Frequently Asked Questions


ACRV and SSO have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ACRV has higher volatility (16.57%) compared to SSO (5.66%). In terms of maximum drawdown, ACRV dropped -95.47% vs SSO's -84.67%.

SSO currently has the higher Sharpe Ratio (2.25 vs 0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ACRV and SSO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer